Anastrozole - Solicitation

The Defense Logistics Agency (DLA) Troop Support is soliciting proposals for a firm-fixed price, requirements-type national contract for Anastrozole 1MG tablets, packaged in 30 and 90 count bottles. This unrestricted, fully competitive acquisition aims to establish a single national supply source to support federal healthcare agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. The contract features a one-year base period with four one-year options, allowing up to a five-year total term. Prospective contractors must comply with commercial item acquisition procedures under FAR Part 12, and proposals will be evaluated using a Lowest Price Technically Acceptable (LPTA) methodology, where technical compliance and past performance (if available) are rated as acceptable or unacceptable, followed by price consideration. Key contract requirements include cGMP-compliant manufacturing, child-proof non-glass unit-of-use packaging compatible with automated dispensing systems such as Baxter ATC Canisters and OptiFill, and robust barcoding compliance adhering to GS1-128, GS1 DataBar, or HIBC standards. Barcodes must encode National Drug Code (NDC), lot number, and expiration date with ANSI/ISO/IEC quality grades of "C" or better. The packaging must meet specified dimensional and labeling criteria to ensure compatibility with FDA and traceability mandates under the Drug Supply Chain Security Act (DSCSA). Inspection and acceptance occur at the destination, typically prime vendor facilities, with the contractor responsible for maintaining production quality, regulatory adherence, and timely delivery within 15 calendar days of order receipt. Invoicing will be conducted with prime vendors, based on business-to-business arrangements, and payment processed through DLA Troop Support Medical in Philadelphia. Proposals must be submitted electronically via the DLA Internet Bid Board System (DIBBS) by April 11, 2025. Submissions require two volumes: a non-price volume containing technical data, certifications, subcontracting plans (if applicable), and manufacturer commitments or certifications; and a separate price volume presenting unit prices exclusive of Federal Excise Tax. Offerors must provide all required representations, certifications, and disclosures electronically via SAM, including Unique Entity Identifiers and CAGE codes. The solicitation incorporates extensive FAR and DFARS clauses governing safeguarding of information, contract terms, whistleblower protections, and supply chain security. Packaging, marking, and barcoding standards referencing commercial healthcare industry and FDA regulations are strictly enforced to ensure product integrity and traceability throughout